BeStock  
股票 › 医疗器械 › BRKR

Bruker 公司 BRKR

美股市值排名 #1501医疗器械常温超导
$61.31 +$3.25 (+5.60%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $61.31 0.00%
开盘$59.00
昨收$58.06
当日区间$58.46 – $61.68
成交量2.01M
市值$9.36B
市盈率(TTM)–
股息率0.33%

股权结构与仓位

谁在持有、谁在做空,以及大资金的流向

机构持股比例94.9%-0.24 个百分点,较上季度
持仓机构数497+5 ,较上季度
内部人近期交易26次买入 / 23次卖出净买入
空头持仓比例8.32% 占流通股回补天数 5.7 · 截至 15 Oct 2026
卖空成交量占比16.3%近5日成交量平均占比

卖空成交量占当日成交量比例

7%16%25%34%Sep '26Oct '26Nov '26

大单净流入,近20个交易日

大单买入减卖出的净额(美元)。该窗口期内:−$80.52M(3个净流入日,17个净流出日)。

按单量净流入,近20个交易日

−$64.9M超大单−$15.6M大单−$16.5M中单−$5.9M小单

超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。

已披露的前五大股东合计持有61.8%的流通股。

最大股东

  • Frank Laukien26.53%
  • Orbis Investment Management Limited11.77%
  • FMR9.80%
  • BlackRock7.49%
  • Pallas Capital Advisors LLC6.22%
  • Joerg Laukien4.93%
  • Vanguard Capital Management, LLC3.65%
  • Strategic Advisers LLC3.48%

按投资者类型

  • Mutual Fund77.44%
  • Individual/Insider31.89%
  • Hedge Fund11.09%
  • Public Company2.49%
  • Government Pension Fund2.46%
  • Private Company0.87%
  • Sovereign Wealth Fund0.24%
  • Insurance Company0.14%

过去6次双周报告中(31 Jul 2026至15 Oct 2026),空头持仓占流通股比例已从8.18%升至8.32%。

近期机构持仓变动

股东类型期间持股变动新持股比例
FMR Mutual Fund 2026/Q3 +3,594,691 9.8%
Sachem Head Capital Management LP Hedge Fund 2026/Q3 +2,915,000 1.9%
Sculptor Capital Management, Inc. Hedge Fund 2026/Q3 +1,355,000 3.0%
AQR Capital Management Hedge Fund 2026/Q3 +1,211,173 1.6%
Viking Global Investors LP Hedge Fund 2026/Q3 +893,491 0.6%
Steadfast Capital Management LP Hedge Fund 2026/Q3 +654,700 0.4%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q3 +653,007 0.9%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +572,931 1.4%
Strategic Advisers LLC Mutual Fund 2026/Q3 +540,931 3.5%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +536,309 0.5%
Forest Avenue Capital Management LP Hedge Fund 2026/Q3 +422,000 0.3%
Nomura Holdings, Inc. Public Company 2026/Q3 +387,889 0.3%
Franklin Resources Mutual Fund 2026/Q3 +310,088 2.1%
Norges Bank Investment Management Sovereign Wealth Fund 2026/Q3 +291,571 0.2%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +268,533 1.7%

按报告期列出的机构买卖动态,变动幅度从大到小排列。

内部人交易

日期内部人职位交易类型股数价格交易后持股
14 Sep 2026 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Derivative Exercise and Sale -2,000 $52.87 92,026
16 Aug 2026 Wolfgang Pusch Open Market Disposition -3,473 $56.90 6,681
14 Aug 2026 Frank Laukien Chairperson & CEO Sale to Issuer -4,760 $57.70 40,421,551
14 Aug 2026 Frank Laukien Chairperson & CEO Other Acquisition +29,463 – 89,570
14 Aug 2026 Frank Laukien Chairperson & CEO Other Derivative Acquisition +71,651 $63.47 71,651
14 Aug 2026 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Sale to Issuer -2,984 $57.70 92,026
14 Aug 2026 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Other Acquisition +14,443 – 42,780
14 Aug 2026 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Other Derivative Acquisition +11,708 $57.70 11,708
14 Aug 2026 Gerald Herman Chief Financial Officer Sale to Issuer -2,724 $57.70 61,062
14 Aug 2026 Gerald Herman Chief Financial Officer Other Acquisition +15,794 – 50,292
14 Aug 2026 Gerald Herman Chief Financial Officer Other Derivative Acquisition +12,803 $63.47 12,803
14 Aug 2026 Burkhard Prause President and CEO of Bruker Energy & Supercon Technologies, Inc. Other Acquisition +3,303 – 9,267
14 Aug 2026 Burkhard Prause President and CEO of Bruker Energy & Supercon Technologies, Inc. Other Derivative Acquisition +2,678 $57.70 2,678
14 Aug 2026 Juergen Srega President of Bruker Biosystems Group & Bruker Daltonics Division Other Acquisition +16,898 – 29,040
14 Aug 2026 Juergen Srega President of Bruker Biosystems Group & Bruker Daltonics Division Other Derivative Acquisition +13,698 $57.70 13,698
14 Aug 2026 Thomas Bures Chief Accounting Officer Other Acquisition +4,035 – 6,264
14 Aug 2026 Wolfgang Pusch Other Acquisition +3,120 – 3,120
14 Aug 2026 Wolfgang Pusch Other Derivative Acquisition +2,529 $57.70 2,529
13 Aug 2026 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Derivative Exercise and Sale -2,000 $57.60 92,026
10 Aug 2026 Frank Laukien Chairperson & CEO Sale to Issuer -4,838 $57.02 40,414,203

数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。

空头持仓(按报告期)

报告日期空头股数占流通股比例回补天数
15 Oct 2026 12,673,281 8.3% 5.7
30 Sep 2026 12,406,174 8.1% 5.1
15 Sep 2026 12,490,387 8.2% 6.3
31 Aug 2026 12,005,384 7.9% 6.3
14 Aug 2026 11,785,398 7.7% 4.0
31 Jul 2026 12,684,689 8.2% 6.6

讨论区

暂无评论——快来第一个聊聊 BRKR。

登录后参与讨论。

Scroll to Top